CBT for Menopause: Improving Sleep and Hot Flashes Without Medication
CBT tailored for menopause may improve insomnia, hot flashes, and mood. New research highlights benefits—and the need for strategies to sustain improvements over time.
Beyond Hot Flashes: The Hidden Toll of Menopausal Sleep Disturbance on Well-Being
Sleep disturbance is common in peri- and postmenopausal women, even in the absence of VMS, and is independently linked to worse quality of life, depression, and anxiety.
Essential Reads: A Primer on Menopausal Hormone Therapy for Mental Health Providers
How should psychiatrists think about hormone therapy in perimenopause? This article explains when, why, and how to consider MHT for perimenopausal women with mood and anxiety symptoms.
Gabapentin: A Non-Hormonal Option for the Treatment of Menopausal Vasomotor Symptoms
Current guidelines list gabapentin as a recommended nonhormonal therapy for vasomotor symptoms in women who cannot or prefer not to use hormone therapy.
Clinical Update 2025: Recommendations on the Use of Antidepressants in Women Taking Tamoxifen
While some antidepressants may affect the metabolism of tamoxifen into its active form, many antidepressants can be used safely in this population.
True or False: Myths and Misconceptions About Bioidentical Hormones for Menopausal Symptoms
While many peri- and post-menopausal women request bioidentical hormones, there is no data to suggest that bioidential hormones are safer or more effective than FDA-approved hormone replacement therapies.
CBT and Mindfulness-Based Interventions for the Treatment of Anxiety and Depression in Perimenopausal Women
This review and meta-analysis reviews the effectiveness of cognitive behavioral therapy and mindfulness interventions for depression, anxiety, and cognitive functioning in women undergoing menopausal transition. Â
Recruiting for Research Study: Pregnenolone Neurosteroid for Menopausal Depression
As of October 2023, the Neurosteroid Intervention for Menopausal and Perimenopausal Depression is no longer recruiting participants. Over the last few years we have heard a great deal about neurosteroids, also known as neuroactive steroids. [...]
Menopause Increases Risk of Relapse in Women with Schizophrenia
Menopause is a period of increased risk for women with schizophrenia spectrum disorders, and women are at higher risk for relapse than their age-matched male counterparts.
Essential Reads: What You Need to Know About Bioidentical Hormone Therapy for Menopausal Symptoms
While many peri- and post-menopausal women request bioidentical hormones, there is no data to suggest that bioidential hormones are safer or more effective than FDA-approved hormone replacement therapies.